MARAL PHARMA
Timeline
8 events since 2023Filings
Financial
Establishments
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 8 days before the deadline
2025
Equity above €150,000 equity €164,874 ▲67.2% With a profit in every financial year since 2023, equity grows to €164,874.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0800104894
Annual accounts 2024 filed PDFmicro format · 21 days before the deadline
2024
Highest result from 2023 to 2025 net €68,766 ▲247% The operating result of €115,403 and the net result of €68,766 are both a record.
Annual accounts 2023 filed PDFmicro format · 13 days before the deadline
2023
IncorporationFounding capital of €10,000, 100 shares · Founder: · Appointment: (director) · published on 31-03-20234 points ▸
- Founder,
- Founding capital, €10,000, 100 shares
- Director appointment, (director (not named in the articles))
- Registered office clause, rue de Taillis-Pré 421, 6200 Châtelineau (Châtelet)
- The deed holds 2 more points.
First establishment Rue de Taillis-pré 421, Châtelet
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank